Merck | MRK - Operating Profit

Stock Price
125.50
Daily Change
-0.40 -0.32%
Monthly
-2.26%
Yearly
-8.49%
Q1 Forecast
123.95

Merck reported EUR1.21B in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Adidas EUR 736M 189M Sep/2025
Adyen EUR 482.78M 31.18M Jun/2025
Akzo Nobel EUR 217M 80M Dec/2025
Alcon AG USD 332M 85M Sep/2025
Amadeus IT EUR 481.5M 12.7M Sep/2025
Amarin USD -1.7M 8.47M Sep/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
BASF EUR 493M 334M Sep/2025
Bayer EUR -543M 556M Sep/2025
Beiersdorf EUR 816M 370M Jun/2025
Covestro EUR 5.39B 5.34B Sep/2025
Danone EUR 1.81B 249M Jun/2025
Fresenius EUR 574M 14M Sep/2025
Fresenius Medical Care EUR 663M 213.06M Dec/2025
Galapagos EUR -41.67M 15.36M Sep/2025
Genmab DKK 360M 172M Jun/2025
Givaudan CHF 364.5M 165.5M Jun/2024
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 352.11M 2.57M Sep/2025
Henkel EUR 1.61B 73M Jun/2025
Hikma Pharmaceutical USD 187M 95M Jun/2025
Infineon EUR 388M 150M Dec/2025
Linde USD 2.41B 68M Sep/2025
Lonza CHF 430M 104M Dec/2024
Merck EUR 1.21B 180M Sep/2025
Novartis USD 4.5B 363M Sep/2025
Philips EUR 719M 390M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
UCB EUR 1B 678M Dec/2024